Women's Health & Pregnancy Clinical Trials

Statistical methods in women's health & pregnancy trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All women's health & pregnancy trials

790 results

• Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer: primary endpoint results, effect estimate with confidence…Phase 2Results postedn = 301NCT01266642
• I-SCREENIndependent statistical analysis of Increasing Screening for Cancer Using EHR-Nudges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06177795).Phase NAResults postedn = 21,123NCT06177795
• Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis: Complete Statistical AnalysisIndependent statistical analysis of Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05399641).Phase 3Results postedn = 150NCT05399641
• IC/BPSIndependent statistical analysis of Real-world Evidence Study on Cystistat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05544695).Phase NAResults postedn = 74NCT05544695
• IDEAL-ICUIndependent statistical analysis of IDEAL-ICU, a randomized phase 3 trial evaluating early versus delayed initiation of renal replacement therapy in ICU patients with septic shock and acute renal failure.Phase 3n = 500NCT01682590
• IGNAZIndependent statistical analysis of Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 54NCT05065970
• IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia: Complete Statistical AnalysisIndependent statistical analysis of IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00524342).Phase 2Results postedn = 7NCT00524342
• Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM): Complete Statistical AnalysisIndependent statistical analysis of Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 107NCT00999596
• IMBSRADQWIUAIndependent statistical analysis of Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and QOL in Women With Intrauterine Adhesion.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 226NCT02746679
• Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: Complete Statistical AnalysisIndependent statistical analysis of Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 10NCT00899574
• Immediate Postplacental IUD Insertion: Complete Statistical AnalysisIndependent statistical analysis of Immediate Postplacental IUD Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02169869).Phase NAResults postedn = 33NCT02169869
• Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion: Complete Statistical AnalysisIndependent statistical analysis of Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 156NCT00737178
• IMmotion151Independent statistical analysis of A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 915NCT02420821
• Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.: Complete Statistical AnalysisIndependent statistical analysis of Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 62NCT04283773
• Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04936230).Phase 2Results postedn = 1NCT04936230
• IMOVAIndependent statistical analysis of Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 11NCT02792959
• Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production: Complete Statistical AnalysisIndependent statistical analysis of Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03883724).Phase NAResults postedn = 56NCT03883724
• Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: Complete Statistical AnalysisIndependent statistical analysis of Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02352103).Phase 3Results postedn = 120NCT02352103
• Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…Phase NAResults postedn = 11NCT02521363
• Improving Cancer Pain Management Through Self-Care: Complete Statistical AnalysisIndependent statistical analysis of Improving Cancer Pain Management Through Self-Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00708019).Phase NAResults postedn = 185NCT00708019
• Improving Care for Women With Urinary Incontinence (EMPOWER): Complete Statistical AnalysisIndependent statistical analysis of Improving Care for Women With Urinary Incontinence (EMPOWER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05515198).Phase NAResults postedn = 400NCT05515198
• Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT): Complete Statistical AnalysisIndependent statistical analysis of Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02794597).Phase NAResults postedn = 119NCT02794597
• Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: Complete Statistical AnalysisIndependent statistical analysis of Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05734989).Phase NAResults postedn = 248NCT05734989
• Improving Urinary Continence and Quality of Life in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Improving Urinary Continence and Quality of Life in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 279NCT01365182
• Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 30NCT03010137
• Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial: Complete Statistical AnalysisIndependent statistical analysis of Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00033917).Phase 3Results postedn = 630NCT00033917
• Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury: Complete Statistical AnalysisIndependent statistical analysis of Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165072).Phase NAResults postedn = 30NCT02165072
• Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics: Complete Statistical AnalysisIndependent statistical analysis of Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04090190).Phase 4Results postedn = 20NCT04090190
• iNOIndependent statistical analysis of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01220687).Phase NAResults postedn = 33NCT01220687
• INS-2Independent statistical analysis of Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 125NCT01030575
• IntegrinIVFIndependent statistical analysis of Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 4Results postedn = 37NCT00621179
• Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART): Complete Statistical AnalysisIndependent statistical analysis of Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 520NCT00505752
• Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin): Complete Statistical AnalysisIndependent statistical analysis of Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations:…Phase 1Results postedn = 48NCT01253174
• Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.: Complete Statistical AnalysisIndependent statistical analysis of Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01574157).Phase NAResults postedn = 74NCT01574157
• Involving Family to Improve Communication in Breast Cancer Care: Complete Statistical AnalysisIndependent statistical analysis of Involving Family to Improve Communication in Breast Cancer Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03283553).Phase NAResults postedn = 132NCT03283553
• IPATunity130Independent statistical analysis of A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer:…Phase 3Results postedn = 579NCT03337724
• Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 61NCT00053365
• Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 1,538NCT02940860
• IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 163NCT02267772
• IXTENDIndependent statistical analysis of Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 62NCT00546364
• JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD): Complete Statistical AnalysisIndependent statistical analysis of JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 299NCT06287073
• KAMELEONIndependent statistical analysis of A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors: primary endpoint results, effect estimate with confidence…Phase 2Results postedn = 20NCT02999672
• KATE2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced…Phase 2Results postedn = 202NCT02924883
• KETAMINEIndependent statistical analysis of Administration of Ketamine to Prevent the Post-operative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00210210).Phase 3Results postedn = 230NCT00210210
• Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): Complete Statistical AnalysisIndependent statistical analysis of Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 12NCT05907213
• KetoPltAggIndependent statistical analysis of IV Ketorolac on Platelet Function Post-Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03805607).Phase 4Results postedn = 40NCT03805607
• KIDPROAMIndependent statistical analysis of Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 144NCT01245595
• KINETICIndependent statistical analysis of Ketamine to Improve Recovery After Cesarean Delivery - Part 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04037085).Phase 2Results postedn = 8NCT04037085
• LADIIIndependent statistical analysis of Labor and Delivery Implant Insertion: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02866643).Phase 3Results postedn = 95NCT02866643
• Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen: Complete Statistical AnalysisIndependent statistical analysis of Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 19NCT00118157

← All therapeutic areas